Tag: kathryn-doyle

Cancer patients want more info about CT risks

| March 24, 2015 | 0 Comments

By Kathryn Doyle (Reuters Health) – – Some cancer patients would like more information on the health risks of their radiology tests, a new study found. “Before completing this study, I believed I understood what patients may wish to know and how to provide that information to them,” said Dr. Raymond Thornton, the study’s lead author from Memorial Sloan-Kettering Cancer Center in New York City …

Continue Reading

Black women less likely to take breast cancer hormone therapy

| February 19, 2015 | 0 Comments

By Kathryn Doyle (Reuters Health) – Among early-stage breast cancer patients in the U.S., black women are less likely than white women to take their prescribed hormone medications, according to a new study that partly – but not entirely – blames economic disparities between races. Black women are less likely to be diagnosed with breast cancer than white women, but more likely to die from it, a …

Continue Reading

'Surveillance' may be safest for low-risk prostate cancer

| December 19, 2014 | 0 Comments

By Kathryn Doyle (Reuters Health) – Among men whose low-risk prostate cancer was managed with so-called active surveillance for up to 15 years, just 1.5 percent died of the cancer, according to new data from a Canadian study.

Continue Reading

Geography may limit access to cancer clinical trials

| December 3, 2014 | 0 Comments

By Kathryn Doyle (Reuters Health) – Where advanced cancer patients live affects the likelihood that they can enroll in a treatment clinical trial, a new study found. Fewer than 10 percent of U.S

Continue Reading

Insurance, income, education tied to survival after lung cancer surgery

| November 7, 2014 | 0 Comments

By Kathryn Doyle (Reuters Health) – – How long patients survive after surgery to remove lung cancer may depend on factors like insurance, income and education, according to a new study. While the stage of the cancer is a more important influence on patient outcomes, the study’s senior author said understanding all of the factors tied to survival can identify groups of people who need more …

Continue Reading

What cancer patients want and what Medicare covers may differ

| September 10, 2014 | 0 Comments

By Kathryn Doyle NEW YORK (Reuters Health) – When asked what Medicare should cover for cancer patients in their last months of life, many patients and their caregivers choose benefits the federal insurance does not offer, like home-based long term care and concurrent palliative care, according to a new study based on interviews. Given an array of options, a limited budget and a chance to discuss …

Continue Reading

Needle biopsies may be underused for breast cancer patients

| June 13, 2014 | 0 Comments

By Kathryn Doyle NEW YORK (Reuters Health) – Most women should undergo a needle biopsy for breast cancer diagnosis, but some surgeons opt for a more invasive procedure instead, according to a new study. “Needle biopsy really is the standard of care,” said senior study author Dr

Continue Reading

Brain activity changes seen after chemo

| May 27, 2014 | 0 Comments

By Kathryn Doyle NEW YORK (Reuters Health) – For some women with breast cancer, changes in brain activity while multitasking could explain “chemo brain” – reduced mental functioning that many experience after chemotherapy, Belgian researchers say.

Continue Reading

Chemo for terminal cancer patients linked to aggressive care

| March 19, 2014 | 0 Comments

By Kathryn Doyle NEW YORK (Reuters Health) – Terminally ill cancer patients who received chemotherapy in the last months of life were more likely to die in an intensive care unit than those who did not receive chemo, according to a new study. Many advanced cancer patients receive chemotherapy that is only meant to make them more comfortable.

Continue Reading

BRCA1 mutation not linked to worse cancer survival

| August 28, 2013 | 0 Comments

By Kathryn Doyle NEW YORK (Reuters Health) – Gene mutations known to increase a woman's risk of getting breast cancer do not appear to also worsen her chance of survival after a diagnosis, a new study suggests. The findings should be reassuring to women with breast cancer, as carrying the BRCA1 mutations is “not a death sentence,” provided patients get good treatment, Dr.

Continue Reading